SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 41.08 |
| Enterprise Value ($M) | 19.42 |
| Book Value ($M) | 104.44 |
| Book Value / Share | 1.56 |
| Price / Book | 0.39 |
| NCAV ($M) | 46.91 |
| NCAV / Share | 0.70 |
| Price / NCAV | 0.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.73 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.34 |
| Current Ratio | 6.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 191.25 |
| Assets | 248.78 |
| Liabilities | 144.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | |||
| 13G/A | Bb Biotech Ag | 5.00 | -8.24 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 14.00 | 35.02 | |
| 13G | BlackRock, Inc. | 5.10 | 0.00 | |
| 13G/A | Atlas Venture Fund X, L.P. | 10.80 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 123,958 | 480,935 | 25.77 | |
| 166,362 | 557,137 | 29.86 | |
| 76,582 | 305,599 | 25.06 | |
| 30,505 | 198,673 | 15.35 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EXEL – Exelixis, Inc. | FDMT – 4D Molecular Therapeutics, Inc. |
| FGEN – FibroGen, Inc. | GERN – Geron Corporation |
| GILD – Gilead Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io